Back to Search
Start Over
Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind,crossover,placebo-controlled study.
- Source :
- International Psychogeriatrics; Sep2006, Vol. 18 Issue 3, p429-436, 8p, 1 Chart, 1 Graph
- Publication Year :
- 2006
-
Abstract
- The article presents a double-blind, crossover, placebo-controlled study on the use of donepezil for negative signs in elderly patients with schizophrenia. Donepezil inhibits cholinesterase, thus enhancing cholinergic neurotransmission. The efficacy of donepezil was in elderly patients with chronic schizophrenia and severe cognitive impairment.
Details
- Language :
- English
- ISSN :
- 10416102
- Volume :
- 18
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- International Psychogeriatrics
- Publication Type :
- Academic Journal
- Accession number :
- 22507171
- Full Text :
- https://doi.org/10.1017/S1041610205003017